{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:05:10Z","timestamp":1785722710103,"version":"3.56.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI106695"],"award-info":[{"award-number":["P01 AI106695"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI107731"],"award-info":[{"award-number":["AI107731"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1 RR024975-01"],"award-info":[{"award-number":["UL1 RR024975-01"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["R01AI099631"],"award-info":[{"award-number":["R01AI099631"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["2 UL1 TR000445-06"],"award-info":[{"award-number":["2 UL1 TR000445-06"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["VE-1"],"award-info":[{"award-number":["VE-1"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.chom.2023.10.004","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T15:12:05Z","timestamp":1698678725000},"page":"1850-1865.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection\/vaccination"],"prefix":"10.1016","volume":"31","author":[{"given":"Jennifer E.","family":"Munt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Henein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan J.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurgun","family":"Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyd","family":"Yount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita M.","family":"Meganck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long Ping V.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Balmaseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravinda M.","family":"DeSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2023.10.004_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029371","article-title":"Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination? The path to a dengue vaccine: learning from human natural dengue infection studies and vaccine trials","volume":"10","author":"de Silva","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.chom.2023.10.004_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/bs.pmbts.2014.10.005","article-title":"A game of numbers: the stoichiometry of antibody-mediated neutralization of Flavivirus infection","volume":"129","author":"Pierson","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.chom.2023.10.004_bib3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.chom.2023.10.004_bib4","series-title":"About dengue","year":"2021"},{"key":"10.1016\/j.chom.2023.10.004_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001760","article-title":"Refining the global spatial limits of dengue virus transmission by evidence-based consensus","volume":"6","author":"Brady","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chom.2023.10.004_bib6","doi-asserted-by":"crossref","first-page":"14688","DOI":"10.1073\/pnas.1508114112","article-title":"Asymptomatic humans transmit dengue virus to mosquitoes","volume":"112","author":"Duong","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2023.10.004_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00280","article-title":"Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections","volume":"5","author":"Grange","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.chom.2023.10.004_bib8","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7024.1","article-title":"Pathogenesis of dengue: dawn of a New Era","volume":"4","author":"Halstead","year":"2015","journal-title":"F1000Res"},{"key":"10.1016\/j.chom.2023.10.004_bib9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4269\/ajtmh.1969.18.997","article-title":"Dengue and Chikungunya virus infection in man in Thailand, 1962\u20131964. IV. Epidemiologic studies in the Bangkok metropolitan area","volume":"18","author":"Halstead","year":"1969","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.chom.2023.10.004_bib10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4269\/ajtmh.1968.17.600","article-title":"An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies","volume":"17","author":"Russell","year":"1968","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.chom.2023.10.004_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4269\/ajtmh.1969.18.573","article-title":"Recurrence of epidemic dengue hemorrhagic fever in an insular setting","volume":"18","author":"Winter","year":"1969","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.chom.2023.10.004_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4269\/ajtmh.1968.17.590","article-title":"An insular outbreak of dengue hemorrhagic fever. I. Epidemiologic observations","volume":"17","author":"Winter","year":"1968","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.chom.2023.10.004_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.1522136113","article-title":"Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort","volume":"113","author":"Katzelnick","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2023.10.004_bib14","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0135","article-title":"Climate change influences on global distributions of dengue and Chikungunya virus vectors","volume":"370","author":"Campbell","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.chom.2023.10.004_bib15","doi-asserted-by":"crossref","first-page":"10787","DOI":"10.1128\/JVI.75.22.10787-10799.2001","article-title":"Assembly and maturation of the Flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively","volume":"75","author":"Mackenzie","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib16","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1128\/jvi.71.11.8475-8481.1997","article-title":"Proteolytic activation of tick-borne encephalitis virus by furin","volume":"71","author":"Stadler","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.chom.2023.10.004_bib18","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1099\/0022-1317-73-8-2155","article-title":"Correlation of E protein binding with cell susceptibility to dengue 4 virus infection","volume":"73","author":"Anderson","year":"1992","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib19","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1128\/jvi.70.12.8765-8772.1996","article-title":"Demonstration of binding of dengue virus envelope protein to target cells","volume":"70","author":"Chen","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/jvi.63.2.564-571.1989","article-title":"Antigenic structure of the Flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model","volume":"63","author":"Mandl","year":"1989","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0065-3527(08)60263-8","article-title":"Epitope mapping of Flavivirus glycoproteins","volume":"31","author":"Heinz","year":"1986","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.chom.2023.10.004_bib22","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of immature Flavivirus particles","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.chom.2023.10.004_bib23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.virol.2015.03.025","article-title":"Shake, rattle, and roll: impact of the dynamics of Flavivirus particles on their interactions with the host","volume":"479\u2013480","author":"Kuhn","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.chom.2023.10.004_bib24","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399408000665","article-title":"Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection","volume":"10","author":"Pierson","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.chom.2023.10.004_bib25","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3390\/v3091562","article-title":"Dengue--quo tu et quo vadis?","volume":"3","author":"Chen","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.chom.2023.10.004_bib26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue","volume":"366","author":"Simmons","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2023.10.004_bib27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.meegid.2009.02.003","article-title":"Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease","volume":"9","author":"Weaver","year":"2009","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.chom.2023.10.004_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0065-3527(03)59009-1","article-title":"Microevolution and virulence of dengue viruses","volume":"59","author":"Rico-Hesse","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.chom.2023.10.004_bib29","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v3122374","article-title":"The human antibody response to dengue virus infection","volume":"3","author":"Wahala","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.chom.2023.10.004_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coviro.2018.03.004","article-title":"The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection","volume":"29","author":"Katzelnick","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.3277268","article-title":"Pathogenesis of dengue: challenges to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.chom.2023.10.004_bib32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0035-9203(87)90042-3","article-title":"Why dengue haemorrhagic fever in Cuba? 2. An integral analysis","volume":"81","author":"Kouri","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.chom.2023.10.004_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni.3081","article-title":"Broad and strong: the ultimate antibody to dengue virus","volume":"16","author":"Coloma","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.chom.2023.10.004_bib34","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"de Alwis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2023.10.004_bib35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","article-title":"Immune response to dengue virus and prospects for a vaccine","volume":"29","author":"Murphy","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.chom.2023.10.004_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108226","article-title":"Antigenic variation of the dengue virus 2 genotypes impacts the neutralization activity of human antibodies in vaccinees","volume":"33","author":"Martinez","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.chom.2023.10.004_bib37","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.celrep.2018.10.006","article-title":"Genetic variation between dengue virus Type 4 strains impacts human antibody binding and neutralization","volume":"25","author":"Gallichotte","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.chom.2023.10.004_bib38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.virusres.2006.04.003","article-title":"Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice","volume":"121","author":"Zulueta","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.chom.2023.10.004_bib39","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/jiw099","article-title":"Homotypic dengue virus reinfections in Nicaraguan children","volume":"214","author":"Waggoner","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.004_bib40","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/infdis\/jiw102","article-title":"Dengue viruses and lifelong immunity: reevaluating the conventional wisdom","volume":"214","author":"Forshey","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.004_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001486","article-title":"Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization","volume":"6","author":"Messer","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chom.2023.10.004_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/ni0715-785a","article-title":"Erratum: Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.chom.2023.10.004_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005554","article-title":"Dissecting the human serum antibody response to secondary dengue virus infections","volume":"11","author":"Patel","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chom.2023.10.004_bib44","first-page":"301","article-title":"Immune enhancement of viral infection","volume":"31","author":"Halstead","year":"1982","journal-title":"Prog. Allergy"},{"key":"10.1016\/j.chom.2023.10.004_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004386","article-title":"Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera","volume":"10","author":"de Alwis","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chom.2023.10.004_bib46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","article-title":"Reconstruction of antibody dynamics and infection histories to evaluate dengue risk","volume":"557","author":"Salje","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.chom.2023.10.004_bib47","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.chom.2023.10.004_bib48","doi-asserted-by":"crossref","first-page":"8376","DOI":"10.1128\/JVI.74.18.8376-8381.2000","article-title":"Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection","volume":"74","author":"Lidbury","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1099\/vir.0.82537-0","article-title":"Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells","volume":"88","author":"Chareonsirisuthigul","year":"2007","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib50","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1016\/j.vaccine.2020.07.056","article-title":"Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus","volume":"38","author":"Dayan","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2023.10.004_bib51","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.vaccine.2020.03.029","article-title":"Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus","volume":"38","author":"Dayan","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2023.10.004_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110930","article-title":"Vaccine-induced antibodies to contemporary strains of dengue virus type 4 show a mechanistic correlate of protective immunity","volume":"39","author":"Gallichotte","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.chom.2023.10.004_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147066","article-title":"Dengue vaccine breakthrough infections reveal properties of neutralizing antibodies linked to protection","volume":"131","author":"Henein","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chom.2023.10.004_bib54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2023.10.004_bib55","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2023.10.004_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8010063","article-title":"A review on dengue vaccine development","volume":"8","author":"Deng","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.chom.2023.10.004_bib57","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2023.10.004_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21384-0","article-title":"A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans","volume":"12","author":"Nivarthi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2023.10.004_bib59","first-page":"351","article-title":"Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naive and dengue-exposed individuals","volume":"215","author":"Henein","year":"2017","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.004_bib60","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.chom.2020.04.007","article-title":"Identification of dengue virus Serotype 3 specific antigenic sites targeted by neutralizing human antibodies","volume":"27","author":"Young","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2023.10.004_bib61","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1128\/JVI.00155-16","article-title":"Functional transplant of a dengue virus Serotype 3 (DENV3)-specific human monoclonal antibody epitope into DENV1","volume":"90","author":"Messer","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003888","article-title":"The structural basis for serotype-specific neutralization of dengue virus by a human antibody","volume":"4","author":"Teoh","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2023.10.004_bib63","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/emmm.201303404","article-title":"A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface","volume":"6","author":"Fibriansah","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.chom.2023.10.004_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00867-17","article-title":"Potent plasmablast-derived antibodies elicited by the National Institutes of Health dengue vaccine","volume":"91","author":"Magnani","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7341","article-title":"A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins","volume":"6","author":"Fibriansah","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2023.10.004_bib66","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/aje\/kwp092","article-title":"The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases","volume":"170","author":"Kuan","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.chom.2023.10.004_bib67","doi-asserted-by":"crossref","first-page":"12233","DOI":"10.1128\/JVI.00247-14","article-title":"Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones","volume":"88","author":"Smith","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib68","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/infdis\/jiz109","article-title":"Beyond neutralizing antibody levels: the epitope specificity of antibodies induced by National Institutes of Health monovalent dengue virus vaccines","volume":"220","author":"Swanstrom","year":"2019","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.004_bib69","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.chom.2023.10.004_bib70","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01861-22","article-title":"Immune imprinting drives human Norovirus potential for global spread","volume":"13","author":"Lindesmith","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.chom.2023.10.004_bib71","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/infdis\/jix609","article-title":"Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America","volume":"217","author":"Moodie","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.004_bib72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"Dengue virus. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers","volume":"349","author":"Fibriansah","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.chom.2023.10.004_bib73","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.chom.2023.10.004_bib74","doi-asserted-by":"crossref","first-page":"18950","DOI":"10.1073\/pnas.1011036107","article-title":"Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354","volume":"107","author":"Kaufmann","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2023.10.004_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01485-19","article-title":"Role of Zika virus envelope protein domain III as a target of human neutralizing antibodies","volume":"10","author":"Gallichotte","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.chom.2023.10.004_bib76","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.1812055115","article-title":"Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies","volume":"116","author":"Raut","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2023.10.004_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00386-22","article-title":"Generation of mature DENVs via genetic modification and directed evolution","volume":"13","author":"Tse","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.chom.2023.10.004_bib78","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2218899120","article-title":"prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis","volume":"120","author":"A Dowd","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2023.10.004_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006934","article-title":"Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes","volume":"14","author":"Gallichotte","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chom.2023.10.004_bib80","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/21645515.2020.1826798","article-title":"DENV-3 precursor membrane (prM) glycoprotein enhances E protein immunogenicity and confers protection against DENV-2 infections in a murine model","volume":"17","author":"Dias","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.chom.2023.10.004_bib81","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/JVI.75.9.4268-4275.2001","article-title":"Mutational evidence for an internal fusion peptide in Flavivirus envelope protein E","volume":"75","author":"Allison","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib82","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbapap.2012.08.014","article-title":"Stability of trimeric DENV envelope protein at low and neutral pH: an insight from MD study","volume":"1834","author":"Dubey","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.chom.2023.10.004_bib83","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(20)30414-1","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children aged 4\u201316 years: a randomised, placebo-controlled, phase 3 trial","volume":"395","author":"Biswal","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2023.10.004_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36702-x","article-title":"A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity","volume":"14","author":"Young","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2023.10.004_bib85","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1016\/j.vaccine.2015.09.008","article-title":"Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study","volume":"33","author":"Rupp","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2023.10.004_bib86","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.vaccine.2019.11.061","article-title":"Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial","volume":"38","author":"Tricou","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2023.10.004_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009258","article-title":"Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)","volume":"15","author":"White","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chom.2023.10.004_bib88","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4269\/ajtmh.2011.10-0592","article-title":"Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques","volume":"84","author":"Osorio","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.chom.2023.10.004_bib89","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1016\/j.vaccine.2011.07.020","article-title":"Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever","volume":"29","author":"Osorio","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2023.10.004_bib90","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1128\/JVI.77.21.11436-11447.2003","article-title":"Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development","volume":"77","author":"Huang","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2023.10.004_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52511-z","article-title":"Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas","volume":"9","author":"Andrade","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chom.2023.10.004_bib92","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2023.10.004_bib93","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01461-15","article-title":"A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies","volume":"6","author":"Gallichotte","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.chom.2023.10.004_bib94","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00380-16","article-title":"Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone","volume":"2","author":"Gallichotte","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.chom.2023.10.004_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000821","article-title":"Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses","volume":"6","author":"Wahala","year":"2010","journal-title":"PLOS Pathogens"},{"key":"10.1016\/j.chom.2023.10.004_bib96","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/14760584.2015.961431","article-title":"Dengue virus envelope protein domain I\/II hinge: a key target for dengue virus vaccine design?","volume":"14","author":"Widman","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.chom.2023.10.004_bib97","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118126119","article-title":"Genomewide CRISPR knockout screen identified PLAC8 as an essential factor for SADS-CoVs infection","volume":"119","author":"Tse","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312823004080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312823004080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T02:41:08Z","timestamp":1731033668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931312823004080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":97,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1931312823004080"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2023.10.004","relation":{},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection\/vaccination","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2023.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}